Prophylaxis and treatment of invasive aspergillosis with voriconazole, posaconazole and caspofungin - review of the literature
<p>Abstract</p> <p>Major progress for the management of invasive aspergillosis has come from the introduction of new antifungals since the late 1990s. Although mortality of invasive aspergillosis remains as high as 30-50%. Backbone of management are prophylaxis, early diagnosis and...
Main Author: | Karthaus M |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-04-01
|
Series: | European Journal of Medical Research |
Online Access: | http://www.eurjmedres.com/content/16/4/145 |
Similar Items
-
Breakthrough invasive fungal infection under the use of posaconazole and voriconazole
by: Sze-Hwei Lee, et al.
Published: (2016-05-01) -
Comparative study of posaconazole and voriconazole for primary antifungal prophylaxis in patients with pediatric acute leukemia
by: Songji Tu, et al.
Published: (2023-11-01) -
Clinical and economic analysis of voriconazole using for treatment of invasive aspergillosis in Russian Federation
by: V. I. Ignatieva, et al.
Published: (2015-06-01) -
Clinical and economic analysis of voriconazole using for treatment of invasive aspergillosis in Russian Federation
by: V. I. Ignatieva, et al.
Published: (2015-06-01) -
MIC Distributions and Evaluation of Fungicidal Activity for Amphotericin B, Itraconazole, Voriconazole, Posaconazole and Caspofungin and 20 Species of Pathogenic Filamentous Fungi Determined Using the CLSI Broth Microdilution Method
by: Andrew M. Borman, et al.
Published: (2017-05-01)